Although the function of this gene in tumor suppression remains unclear, we speculate that in mammals, oncogenesis-associated up-regulation of ceramide synthase 2 promotes the synthesis of GSLs containing very-long-chain fatty acids and the production of antibodies that react with them, resulting in the suppression of oncogenesis. Here, CERS2 is linked to neoplasm.